Literature DB >> 321410

The relative efficacy of methylphenidate (ritalin) and behavior-modification techniques in the treatment of a hyperactive child.

M Wulbert, R Dries.   

Abstract

Drug versus placebo effects were contrasted with those of contingency management in the treatment of a hyperactive child. Several criterion behaviors were monitored in two different settings to gauge the breadth and generalizability of drug and behavior-management effects. Medication and contingency management effects were both found to be situation specific. No interaction effects were found. Accuracy of task performance, amount of eye contact with the experimenters, frequency of repetitive hand movements, and distractible behavior were apparently unaffected by medication (Ritalin versus placebo) within the clinic. A multiple-baseline design incorporating contingency reversals revealed the reinforcement contingencies to be the crucial variable controlling behavior within the clinic. Medication effects were shown to be significant within the home setting where reinforcement contingencies were not changed. While aggressive behavior decreased as a function of Ritalin, repetitive hand movements increased.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321410      PMCID: PMC1311146          DOI: 10.1901/jaba.1977.10-21

Source DB:  PubMed          Journal:  J Appl Behav Anal        ISSN: 0021-8855


  17 in total

Review 1.  Training parents as behavior therapists: a review.

Authors:  B P Berkowitz; A M Graziano
Journal:  Behav Res Ther       Date:  1972-11

2.  The generalization of newly acquired behaviors by parents and child across three different settings. A study of an autistic child.

Authors:  M Wulbert; R Barach; M Perry; J Straughan; S Sulzbacher; K Turner; N Wiltz
Journal:  J Abnorm Child Psychol       Date:  1974-06

3.  Studies in hyperkinetic behavior. II. Laboratory and clinical evaluations of drug treatments.

Authors:  J G Millichap; E E Boldrey
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Methylphenidate and the activity of hyperactives in the informal setting.

Authors:  M J Ellis; P A Witt; R Reynolds; R L Sprague
Journal:  Child Dev       Date:  1974-03

5.  Methylphenidate and thioridazine: learning, reaction time, activity, and classroom behavior in disturbed children.

Authors:  R L Sprague; K R Barnes; J S Werry
Journal:  Am J Orthopsychiatry       Date:  1970-07

6.  Porteus maze performance of hyperactive boys after training in self-directed verbal commands.

Authors:  H Palkes; M Stewart; B Kahana
Journal:  Child Dev       Date:  1968-09

7.  Behavior modification and the brat syndrome.

Authors:  M E Bernal; J S Duryee; H L Pruett; B J Burns
Journal:  J Consult Clin Psychol       Date:  1968-08

8.  Training impulsive children to talk to themselves: a means of developing self-control.

Authors:  D H Meichenbaum; J Goodman
Journal:  J Abnorm Psychol       Date:  1971-04

9.  The effect of methylphenidate on attentive behavior and autonomic activity in hyperactive children.

Authors:  N J Cohen; V I Douglas; G Morgenstern
Journal:  Psychopharmacologia       Date:  1971

10.  Reduction of hyperactive behavior by conditioning procedures alone and combined with methylphenidate (Ritalin).

Authors:  D E Christensen; R L Sprague
Journal:  Behav Res Ther       Date:  1973-08
View more
  4 in total

Review 1.  The effectiveness of behavior modification on hyperkinesis.

Authors:  L Hersher
Journal:  Child Psychiatry Hum Dev       Date:  1985

2.  Ritalin vs. response cost in the control of hyperactive children: a within-subject comparison.

Authors:  M D Rapport; H A Murphy; J S Bailey
Journal:  J Appl Behav Anal       Date:  1982

3.  Clinical behavioral pharmacology: methods for evaluating medications and contingency management.

Authors:  L D Burgio; T J Page; R M Capriotti
Journal:  J Appl Behav Anal       Date:  1985

4.  Behavioural treatment of hyperactive children.

Authors:  R T Bidder; O P Gray; R Newcombe
Journal:  Arch Dis Child       Date:  1978-07       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.